Cargando…
OR32-01 Clinical Performance Of Multiplatform Molecular Diagnostic Testing Of Cytology Indeterminate Thyroid Nodules: A Blinded, Single Institution Observational Study With Surgical Pathology And Surveillance Follow Up
Disclosure: N.A. Cipriani: None. T. Antic: None. A. Banizs: Employee; Self; Interpace Diagnostics. S.D. Finkelstein: Employee; Self; Employee of Interpace Diagnostics. Background: Genetic analysis of final needle aspiration biopsies (FNAB) can improve the diagnostic accuracy of cytology indeterminat...
Autores principales: | Cipriani, Nicole A, Antic, Tatjana, Banizs, Anna, Finkelstein, Sydney David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554446/ http://dx.doi.org/10.1210/jendso/bvad114.2056 |
Ejemplares similares
-
PSAT379 Performance of a Raman Fingerprint in Thyroid Nodules with Indeterminate Cytology: A Prospective Blinded Monocentric Study
por: Palermo, Andrea, et al.
Publicado: (2022) -
Multiplatform molecular test performance in indeterminate thyroid nodules
por: Lupo, Mark A., et al.
Publicado: (2020) -
OR27-2 Inter-reader Agreement of ATA Sonographic Risk In Thyroid Nodules With Indeterminate Cytology
por: Linares, Maria, et al.
Publicado: (2019) -
Malignancy Risk in RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Real-World Clinical Experience
por: Lu, Joseph, et al.
Publicado: (2021) -
MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020)